Exhibit 31.1

SECTION 302
CERTIFICATION

I,
Daniel Glassman, certify that:

1.
I have reviewed this amendment to annual report on Form 10-K/A of Bradley
Pharmaceuticals, Inc.;

2.
Based on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in light of
the circumstances under which such statements were made, not misleading with respect to
the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included
in this report, fairly present in all material respects the financial condition, results
of operations and cash flows of the registrant as of, and for, the periods presented in
this report;

4.
The registrants other certifying officer(s) and I are responsible for establishing
and maintaining disclosure controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in
Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

| | a. |  | Designed
such disclosure controls and procedures, or caused such             disclosure controls
and procedures to be designed under our             supervision, to ensure that material
information relating to the             registrant, including its consolidated
subsidiaries, is made known             to us by others within those entities,
particularly during the             period in which this report is being prepared;
| | -- |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | b. |  | Designed
such internal control over financial reporting, or caused             such internal
control over financial reporting to be designed under             our supervision, to
provide reasonable assurance regarding the             reliability of financial reporting
and the preparation of financial             statements for external purposes in
accordance with generally             accepted accounting principles;
| | -- |  | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | c. |  | Evaluated
the effectiveness of the registrants disclosure controls             and procedures
and presented in this report our conclusions about             the effectiveness of the
disclosure controls and procedures, as of             the end of the period covered by
this report based on such             evaluation; and
| | -- |  | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | d. |  | Disclosed
in this report any change in the registrants internal             control over
financial reporting that occurred during the             registrants most recent
fiscal quarter (the registrants fourth             fiscal quarter in the case of an
annual report) that has materially             affected, or is reasonably likely to
materially affect, the             registrants internal control over financial
reporting; and
| | -- |  | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

5.
The registrants other certifying officer(s) and I have disclosed, based on our most
recent evaluation of internal control over financial reporting, to the registrants
auditors and the audit committee of the registrants board of directors (or persons
performing the equivalent functions):

| | a. |  | All
significant deficiencies and material weaknesses in the design             or operation
of internal control over financial reporting which are             reasonably likely to
adversely affect the registrants ability to             record, process, summarize
and report financial information; and
| | -- |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | b. |  | Any
fraud, whether or not material, that involves management or             other employees
who have a significant role in the registrants             internal control over
financial reporting.
| | -- |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Date: April 30, 2007

/s/ Daniel Glassman 
Daniel Glassman 
Chief Executive Officer, 
President and Member of the Board of Directors 
(Principal Executive Officer)